Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Miyamoto, Atsushi"" wg kryterium: Autor


Wyświetlanie 1-1 z 1
Tytuł:
Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.
Autorzy:
Ueno M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi ku, Yokohama, 241-0815, Japan. .
Morizane C; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Mizusawa J; Japan Clinical Oncology Group/Operations Office, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Kataoka T; Japan Clinical Oncology Group/Operations Office, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Ozaka M; Hepato-Biliary-Pancreatic Medicine Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
Okano N; Department of Medical Oncology, Faculty of Medicine, Kyorin University, Mitaka, Tokyo, Japan.
Sugimori K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Sunto-Gun, Shizuoka, Japan.
Shimizu S; Department of Gastroenterology, Saitama Cancer Center, Kita-Adachi-Gun, Saitama, Japan.
Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Yamamoto T; Department of Surgery, Kansai Medical University Hospital, Hirakata, Osaka, Japan.
Sano K; Department of Surgery, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan.
Tobimatsu K; Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Katanuma A; Center for Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
Miyamoto A; Department of Hepatobiliary and Pancreatic Surgery, Osaka National Hospital, Osaka, Japan.
Yamaguchi H; Department of Surgery, Jichi Medical University, Shimono, Tochigi, Japan.
Nishina T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Shirakawa H; Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
Kojima Y; Department of Gastroenterology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Oono T; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kawamoto Y; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
Furukawa M; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Iwai T; Department of Gastroenterology, Kitasato University Hospital, Sagamihara, Kanagawa, Japan.
Sudo K; Gastrointestinal Medical Oncology, Chiba Cancer Center, Chiba, Japan.
Miyakawa H; Department of Bilio-Pancreatology, Sapporo-Kosei General Hospital, Sapporo, Japan.
Yamashita T; Department of Gastroenterology, Kanazawa University, Kanazawa, Ishikawa, Japan.
Yasuda I; Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, Toyama, Japan.
Takahashi H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Shioji K; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
Shimizu K; Department of Gastroenterology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
Nakagohri T; Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Kamata K; Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osakasayama, Osaka, Japan.
Ishii H; Gastrointestinal Medical Oncology, Chiba Cancer Center, Chiba, Japan.
Furuse J; Department of Medical Oncology, Faculty of Medicine, Kyorin University, Mitaka, Tokyo, Japan.
Pokaż więcej
Corporate Authors:
members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
Źródło:
Scientific reports [Sci Rep] 2021 Jun 18; Vol. 11 (1), pp. 12885. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Biliary Tract Neoplasms/*drug therapy
Biliary Tract Neoplasms/*pathology
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biliary Tract Neoplasms/complications ; Biomarkers ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Disease Management ; Female ; Humans ; Kaplan-Meier Estimate ; Kidney Diseases/diagnosis ; Kidney Diseases/etiology ; Kidney Function Tests ; Male ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Treatment Outcome ; Gemcitabine
Czasopismo naukowe
    Wyświetlanie 1-1 z 1

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies